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ABSTRACT | Although transcutaneous electrical nerve 
stimulation (TENS) has been proposed to modulate 
pain and the mechanisms underlying analgesia remain 
poorly understood, evidence of anti-inflammatory 
effect is more limited. The purpose of this study was 
to examine the opioidergic mechanisms of TENS 
effects in two different frequencies on pain and 
inflammatory edema in the ankle sprain model in rats. 
Threshold to mechanical stimulation was utilized to 
examine the changes produced by intraperitoneal 
injection of non-selective opioid antagonist naloxone 
on the antihyperalgesic effect induced by a 20-min 
period of 2Hz or 100Hz TENS in the ankle sprain 
model, produced by manually overextending the 
lateral ligaments. Ankle sprain induced a long-lasting 
reduction in paw withdrawn latency (PWL) after 30 
minutes for up to 24 hours in sham TENS (SH-TENS) 
treated rats. The reduced PWL after the induction 
of ankle sprain was restored partially at 0,1,2,3 and 
6, but not 24 hours, after the termination of 2 Hz-
TENS (LF-TENS). In 100Hz (HF-TENS) the reduction 
in PWL was shorter than LF-TENS and both LF and 
HF effects were fully blocked in naloxone-treated 
rats. LF- and HF-TENS treated rats did not reach 
the elevation of edema and presented a progressive 
edema reduction for over 24 hours when compared to 
28
SH-TENS group. Both effects were reduced by naloxone. 
TENS-induced antihyperalgesic and anti-edematous 
effects observed in ankle sprain model were mediated 
by the endogenous opioid system.
Keywords | Transcutaneous Electric Nerve Stimulation; 
Ankle Injuries; Pain, Inflammation.
RESUMO | Embora estimulação elétrica nervosa 
transcutânea  (TENS)  tem sido proposta para modular 
a dor e os mecanismos subjacentes a analgesia 
permanecem mal compreendidos, evidências do efeito 
anti-inflamatório são mais limitadas. O objetivo deste 
estudo foi examinar os mecanismos opioidérgicos de 
efeitos de TENS em duas frequências diferentes sobre 
dor e edema inflamatório no modelo de entorse de 
tornozelo em ratos. Limiar de estimulação mecânica foi 
utilizado para examinar as alterações produzidas pela 
injeção intraperitoneal de naloxona, um antagonista 
opioide não-seletivo, sobre o efeito anti-hiperalgésico 
induzido por um período de 20 min de 2Hz ou 100Hz 
de TENS no modelo de entorse de tornozelo, produzido 
ultrapassando manualmente os ligamentos laterais. 
Entorse de tornozelo induziu uma redução duradoura 
na latência de retirada da pata  (PWL)  depois de 30 
minutos até 24 horas em ratos tratados para TENS 
“simulada” (SH-TENS). A PWL reduzida após a indução 
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de entorse de tornozelo foi restaurada parcialmente em 0,1,2,3 
e 6, mas não em 24 horas, após o término do 2 Hz-TENS (LF-
TENS). Em 100Hz  (HF-TENS)  a redução de PWL foi menor 
do que LF-TENS e tanto os efeitos HF e LF foram totalmente 
bloqueados em ratos tratados com naloxona. Ratos tratados 
com LF- e HF-TENS não alcançou a elevação do edema e 
apresentaram uma redução progressiva do edema por mais 
de 24 horas, quando comparado ao grupo SH-TENS. Ambos 
os efeitos foram reduzidos pela naloxona. Efeitos anti-
hiperalgésicos induzidos por TENS e efeitos antiedematosos 
observados no modelo de entorse de tornozelo foram 
mediados pelo sistema de opioides endógenos.
Descritores | Estimulação Elétrica Nervosa Transcutânea; 
Traumatismos do Tornozelo; Dor, Inflamação.
RESUMEN | Aunque la estimulación nerviosa eléctrica 
transcutánea (TENS) ha sido propuesta para modular el dolor 
y los mecanismos subyacentes a la analgesia sigue siendo mal 
entendida, la evidencia del efecto antiinflamatorio es limitada. 
El propósito de este estudio fue examinar los mecanismos 
opioidérgicos de los efectos de la TENS en dos frecuencias 
diferentes sobre el dolor y el edema inflamatorio en un modelo 
de ratas con esguince de tobillo. Se utilizó el umbral a la 
estimulación mecánica para examinar los cambios producidos 
por inyección intraperitoneal del antagonista opiáceo no 
selectivo naloxona sobre el efecto antihiperalgésico inducido 
por un período de 20 minutos de 2Hz o 100Hz TENS en el 
modelo con esguince de tobillo, producido por sobrecarga 
manual de los ligamentos laterales. El esguince de tobillo 
indujo una reducción de larga duración en latencia de la pata 
retraída (PWL) después de 30 minutos por hasta 24 horas en 
simulación de la TENS (SH-TENS) para las ratas tratadas. El 
PWL reducido después de la inducción del esguince de tobillo 
fue restaurado parcialmente en 0,1,2,3 y 6, pero no por 24 
horas, después de la terminación de 2 Hz-TENS (LF-TENS). 
La reducción en PWL fue menor que LF-TENS en 100Hz 
(HF-TENS) y tanto los efectos de LF como de HF fueron 
completamente bloqueados en ratas tratadas con naloxona. 
Las ratas tratadas con LF- y HF-TENS no alcanzaron la 
elevación del edema y presentaron una reducción progresiva 
del edema durante más de 24 horas en comparación con 
el grupo SH-TENS. Ambos efectos fueron reducidos por la 
naloxona. Efectos antihiperalgésicos y antiedematosos TENS-
inducidos observados en el modelo con esguince de tobillo 
fueron mediados por el sistema opioide endógeno.
Palabras clave | Estimulación Eléctrica Transcutánea del Nervio; 
Traumatismos del Tobillo; Dolor; Inflamación.
INTRODUCTION
Transcutaneous electrical nerve stimulation (TENS) 
is a noninvasive treatment commonly used to manage 
pain. While strongly supporting an analgesic effect on 
pain thresholds1-5, evidence of anti-inflammatory effect 
of TENS is more limited.
Two different theories have been proposed to explain 
TENS-induced analgesia. First, the gate control theory 
of pain6,7 proposed that the stimulation of large-diameter 
afferent fibers inhibits second order neurons in the 
dorsal horn and prevents pain impulses carried by small-
diameter fibers from reaching higher brain centers. 
Second, TENS activates pain inhibitory pathways 
stimulating the release of endogenous opioids8 and 
serotonin9. Endogenous opioid peptides such as beta-
endorphin activate opioid receptors both at the level of 
the spinal cord10,11 and on peripheral sensory neurons at 
the site of inflammation12,13. In inflammatory pain model 
in rats serotonin also contributes to TENS-induced 
analgesia via spinal 5-HT2A  and 5-HT3, but not 
5-HT1A  receptors and 5-HT3  receptors involves 
GABAergic, enkephalinergic, and other classes of spinal 
intrinsic neurons related to gate control and descendent 
pain inhibitory pathways14.
The spinal cord is also involved in the modulation 
of peripheral inflammatory edema15,16. The spinal 
segmental modulation of dorsal root reflex generation 
seems to be the main responsible for peripheral control 
of the neurogenic component of inflammation17. 
Recently, it was demonstrated that TENS could 
suppress the spinal release of substance P and 
proinflammatory cytokines18. Although, TENS has 
proved to be an effective therapy against several pain 
conditions, few studies have shown that TENS can 
modulate or suppress the inflammatory edema.
Thus, the purpose of this study was to examine 
the opioidergic mechanisms of TENS effects in two 
different frequencies on pain and inflammatory edema 
in ankle sprain model in rats.
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METHODOLOGY
Animals
The experiments were conducted using male Wistar 
rats (200-250g) from the main animal house of the 
Universidade Federal de Alfenas (Unifal-MG). Animals 
were housed at a controlled temperature (24±2°C) and 
on a 12-hour light-dark cycle (dark cycle beginning at 
7 am), and they had free access to food and water. The 
experiments were approved by Ethics Committee (CEUA – 
Unifal-MG, protocol 591/2014).
Procedure for ankle sprain
The rats were anesthetized with isoflurane vaporized in 
air (3% for induction and 2.0% for maintenance). Ankle 
sprain was produced by manually overextending the lateral 
ligaments by the same person, without breaking them, to 
imitate a lateral ankle sprain in a human19,20. Anesthesia 
was discontinued and the rats recovered from anesthesia 
within 5-10 minutes. A single operator performed this 
procedure to guarantee the same strength of the procedures.
Inflammatory edema
Paw edema was measured with a plethysmometer 
(Model 7140, Ugo Basile, Rome, Italy). Briefly, the paw is 
inserted into water, contained in a special water cell whose 
resistance is changed due to the immersion of the animals’ 
paws. This resistance change is calibrated in ml and shown 
on the electronic monitor21. After determination of the 
basal volume, the animals (n=6 per group) were divided into 
experimental groups in such a way that the mean volumes 
of the different groups were similar. The paw volume was 
measured 0, 1, 2, 3, 6 and 24 h after TENS or sham treatment.
Paw mechanical sensitivity
Mechanical sensitivity was measured using an 
electronic von Frey device (Insight Equipamentos, 
Ribeirão Preto, SP, Brazil). Briefly, a pressure-meter which 
consisted of a hand-held force transducer fitted with a 
0.5mm2 polypropylene tip was applied perpendicularly 
to the central area of the hindpaw with a gradual increase 
in pressure22. The corresponding force was recorded (in 
grams). The smaller the force applied for inducing paw 
withdrawal, the more sensitive the animals were to the 
nociception stimulus.
Drug treatment
To evaluate the possible involvement of opioidergic 
mechanisms in antinociceptive effect of TENS, naloxone 
hydrochloride (Sigma, St. Louis, MO, USA), an opioid 
receptor antagonist, was dissolved in saline and injected 
intraperitoneally 10 minutes before the stimulation (NAL 
groups). Saline (1ml) was used as control (SAL groups).
TENS Treatment
Rats were lightly anesthetized with isoflurane 
(2%, 20 minutes) and TENS (Neurodyn TENS unit, 
IBRAMED, SP, Brazil) was applied to the ankle joint. 
One-inch round pregelled electrodes were placed on the 
medial and lateral aspects of the ankle joint (Figure 1). 
Sensory-intensity TENS was determined by increasing 
the intensity until a palpable muscle contraction was 
elicited and then reducing the intensity to just below 
that point. Rats received either 1) low-frequency TENS 
to the inflamed ankle joint at sensory intensity (LF-
TENS, 10Hz; 20 minutes); 2) high-frequency TENS at 
sensory intensity (HF-TENS, 100Hz; 20 minutes); or 
3) Sham TENS (SH-TENS, 0Hz; 20 minutes) during 
which the animal was placed in the same apparatus, 
had electrode placed but no current was applied. The 
pulse duration is constant at 100μs and intensities were 
constant at sensory-level intensity and are based on 
those used clinically8.
Figure 1. Electrodes placed on the medial and lateral aspects of 
the ankle joint.
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Experimental Protocol
Each rat was initially taken to determine its baseline 
PWL (baseline). The animal was then anesthetized with 
isoflurane and submitted to the ankle sprain procedure. 
PWL were again determined 30 minutes later (sprain). 
Saline (SAL groups, 1 ml) or naloxone (NAL groups, 
10mg/kg, 1ml, i.p.) was injected and 10 minutes later 
HF-, LF- or SH-TENS were applied for 20 minutes. 
PWL were measured five minutes (T0), one (T1), two 
(T2), three (T3), six (T6) and twenty-four hours (T24) 
after the period of stimulation.
Statistics
Data were analyzed using the GraphPad software 
program Version 5.0 and expressed as the mean ± 
S.E.M. Statistically significant differences between 
the groups were calculated using two-way analysis 
of variance (Anova) followed by the Newman–Keuls 
post-hoc test. P-values less than 0.05 were considered 
significant.
RESULTS
The PWL (Figure 2) and edema (Figure 3) were 
measured before and after the ankle sprain. The PWL 
and edema baselines in each group were not different in 
all the experiments in the present study.
Ankle sprain induced a long-lasting reduction in PWL 
for up to 24 hours in SH-TENS/SAL rats (Figure 2). In 
this group, naloxone (SH-TENS/NAL) or saline-treated 
(SH-TENS/SAL) rats were not different throughout 
the period of observation. After the LF-TENS/SAL, 
the PWL was increased at 0, 1, 2, 3 and 6 hours, but 
were not different from SH-TENS/SAL after 24 hours 
(Figure 2A). This antinociceptive effect was fully blocked 
in naloxone-treated rats (LF-TENS/NAL) at all evaluated 
times. Similar results were obtained with HF-TENS-
treated rats (Figure 2B). After the HF-TENS/SAL, the 
PWL was increased at 0, 1 and 2 hours, but were not 
different from SH-TENS/SAL after 3, 6 or 24 hours. 
This antinociceptive effect was shorter than LF-TENS/
SAL, but also fully blocked in naloxone-treated rats 
(HF-TENS/NAL) at all times.
Figure 2. Effect of LF-TENS (A) or HF-TENS (B) application on sprain-induced hyperalgesia. The experiment was conducted before 
(baseline) and after ankle sprain (sprain) and the mechanical threshold was measured 5 min after TENS (T0) and at different times T1, 
T2, T3, T6 and T24 hours. The animals were pretreated (dashed arrow) with saline (SAL) or naloxone (NAL) and then 10 minutes later 
were treated with TENS (black arrow). Points are means ± SD of 6 rats per group. p < 0.05 compared with SH-TENS/SAL (*).
The data in A were different regarding treatments (F = 26,09; P < 0.001), time (F = 380,98; P < 0.001) and had significant treatment x time interaction (F = 14,34; P < 0.001). The data in B were signifi-
cantly different regarding treatments (F = 23,94; P < 0.001), time (F = 324,70; P < 0.001) and had significant treatment x time interaction (F = 14,34; P < 0.001).
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Figure 3. Effect of LF-TENS (A) or HF-TENS (B) application on sprain-induced edema. The experiment was conducted before (baseline) 
and after ankle sprain (sprain) and the mechanical threshold was measured 5 min after TENS (T0) and at different times T1, T2, T3, 
T6 and T24 hours. The animals were pretreated (dashed arrow) with saline (SAL) or naloxone (NAL) and then 10 minutes later were 
treated with TENS (black arrow). Points are means ± SD of 6 rats per group. p < 0.05 compared with SH-TENS/SAL (*) or LF- or HF-
TENS/SAL groups (#). The data in A were significantly different regarding treatments (F = 25,89; P < 0.001), time (F = 127,11; P < 0.001) 
and had significant treatment x time interaction (F = 8,71; P < 0.001). The data in B were significantly different regarding treatments 
(F  =  56,04; P  <  0.001) and were not significantly different regarding time (F  =  207,55; P  <  0.001) or treatment x time interaction 
(F = 13,85; P < 0.001).
Before the induction of ankle sprain, the average 
volume of the foot was just below 2 ml (Figure 3). The 
ankle swelled rapidly after the sprain induction, almost 
doubling its volume in after SH-TENS treatment. 
For this group, naloxone (SH-TENS/NAL) or saline-
treated (SH-TENS/SAL) rats were not different from 
SH-TENS rats throughout the period of observation.
LF-TENS/SAL-treated rats had a decreased edema 
less intense than SH-TENS/SAL-treated rats at all 
times after ankle sprain (Figure 3A). This decrease in 
edema after LF-TENS was blocked after pre-treatment 
with naloxone (LF-TENS/NAL) 1 hour after the ankle 
sprain and maintained for 24 hours.
HF-TENS/SAL-treated rats had a decreased edema 
less intense than SH-TENS/SAL-treated rats at all 
times after ankle sprain (Figure 3B). This decrease in 
edema after LF-TENS was blocked after pre-treatment 
with naloxone (HF-TENS/NAL) 3 hours after the 
ankle sprain and maintained for 24 hours.
DISCUSSION
TENS has been extensively used for different 
purposes mainly for pain relief. However, the mechanism 
involved in TENS analgesic effect is not completely 
understood23. In the present study, we extend these 
observations showing that a single session of LF-TENS 
or HF-TENS (10 or 100Hz) produced long-lasting 
reduction in mechanical inflammatory hyperalgesia and 
edema induced by ankle sprain in rat hind paw.
TENS effects depend on activation of opioid 
receptors by endogenously released opioids8. In fact, 
the participation of endogenous opioids on the effect of 
TENS, including endomorphin, endorphin, enkephalin 
Elisei et al. TENS on pain and edema in rat ankle sprain
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and dynorphin, has been extensively described24. TENS-
stimulated opioids can reduce the activity of nociceptive 
neurons and the release of important neurotransmitters, 
such as substance P, which are involved in the 
transmission of nociceptive information18.
In the present study, we show that endogenous 
opioids are involved in the antinociceptive effect of 
TENS against inflammatory pain evoked by ankle 
sprain. The opioids released can counteract the 
migration of neutrophils to the site of inflammation 
and this effect might account for the effect of TENS 
against hyperalgesia and edema. The migration of 
neutrophils to the inflammatory site is a crucial step in 
the development of inflammatory hyperalgesia22.
An important question point emerging from these 
results is the local from where opioids are released by 
TENS stimulation. There is evidence that opioids can 
be released through the entire nociceptive system, 
including peripherally, in the spinal cord and supra-
spinal sites25.
In the periphery, two different mechanisms may result 
in a decreased nociception. First, opiate agonists may act 
directly on opioid receptors of primary afferent neurons26,27. 
It has been shown that peripheral opioid receptors of 
primary afferents may be physiologically important 
because they may represent targets for endogenous opioids 
released during inflammatory process26.
Second, opioids can reduce inflammation through 
actions on leukocytes28. Numerous leukocytes, 
including lymphocytes, macrophages, monocytes, and 
polymorphonuclear cells such as neutrophils have been 
reported to express opioid receptors29. Direct activation 
of opioid receptor reduced neutrophil migration toward 
the inflammatory site30. In TENS effect opioid might be 
affecting several steps involved in neutrophil migration 
such as neutrophil adhesion by reducing adhesion 
molecules expression, chemokines-induced neutrophil 
chemotaxis and edema31.
TENS can also stimulate the release of opioids in the 
spinal dorsal horn where they exhibit inhibitory actions 
against excitatory transmission24. The mechanisms 
activated by TENS differ according to the frequency of 
stimulation. Low-frequency TENS (2–10Hz) increases 
the spinal release of met-enkephalin, endomorphin 
and beta-endorphins, whereas high-frequency TENS 
(50-100Hz) increases the spinal release of dynorphin 
and both activate pain inhibitory pathways24,32 that 
are represented by serotonergic and noradrenergic 
fibers from rostral ventromedial medulla33. This central 
mechanism might be involved in the TENS effect 
against inflammatory edema.
In summary, using the ankle sprain model, an 
effect of TENS was demonstrated on hyperalgesia 
and edema. The effect lasted for several hours and is 
different when compared LF-TENS higher than HF-
TENS. For the first time, an effect of TENS against 
inflammatory edema was demonstrated. Furthermore, 
the TENS-induced analgesia observed was mediated by 
the endogenous opioid system and opioids are involved 
in effect of TENS against inflammatory edema. These 
results suggest that the antihyperalgesic action of TENS 
might be triggered by a peripheral and/or central-acting 
opioid mechanism.
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